Skip to content
Disclosery

EXANE DERIVATIVES: ABBV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ABBV, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,517 ABBV shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,517 shares
    Change vs previous 13F -1,221 shares

    0.13% of the 13F portfolio, value $232,317.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,738 shares
    Change vs previous 13F -527 shares

    0.13% of the 13F portfolio, value $443,860.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,265 shares
    Change vs previous 13F -406 shares

    0.11% of the 13F portfolio, value $442,095.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,671 shares
    Change vs previous 13F +35 shares

    0.1% of the 13F portfolio, value $396,006.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,636 shares
    Change vs previous 13F -702 shares

    0.1% of the 13F portfolio, value $428,730.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4,338 shares
    Change vs previous 13F -229 shares

    0.14% of the 13F portfolio, value $469,480.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,567 shares
    Change vs previous 13F -6,329 shares

    0.15% of the 13F portfolio, value $489,376.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 10,896 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $954,406.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).